NewcelX Employees

As of December 31, 2024, NewcelX had 15 total employees, including 11 full-time and 4 part-time employees. The number of employees increased by 3 or 25.00% compared to the previous year.

Employees

Change (1Y)

Growth (1Y)

25.00%

Revenue / Employee

n/a

Profits / Employee

-$1,232,679

Market Cap

12.58M

Employees Chart

Employees History

Date	Employees	Change (1Y)	Growth (1Y)	Full-Time	Part-Time
Dec 31, 2024	15	3	25.00%	11	4
Dec 31, 2023	12	-19	-61.29%	12	0
Dec 31, 2022	31	-1	-3.13%	31	0
Dec 31, 2020	32	-	-	28	4

Related Stocks

Company Name	Employees
BioCardia	20
Quantum BioPharma	17
Cellectar Biosciences	11
Cocrystal Pharma	11
Allarity Therapeutics	7
Traws Pharma	7
Cadrenal Therapeutics	4
Hoth Therapeutics	3

Employee Rankings

NCEL News

13 days ago - NewcelX Announces Updated Corporate Presentation Ahead of Key Spring 2026 Investor and Partnering Conferences - PRNewsWire
4 weeks ago - NewcelX Announce Positive Results from International Collaborative Study Exploring Advanced Biomaterial Approaches for Stem Cell-Derived Islet Delivery in Type 1 Diabetes Without Immune Suppression - PRNewsWire
5 weeks ago - NewcelX Appoints Dr. Julien Boisdron, a Swiss Big Pharma Leader in Diabetes Innovation, to Its Scientific Advisory Board - PRNewsWire
2 months ago - NewcelX Expands Intellectual Property Footprint with Publication of DOXA Patent Application in China - PRNewsWire
3 months ago - NewcelX Strengthens Scientific Advisory Board with Appointment of Jeremy Shefner, MD, PhD, Chief Medical Officer at the Barrow Neurological Institute - PRNewsWire
3 months ago - NewcelX Announces Scientific Leadership with the Head of Division of Medical Neurosciences at the Department of Neurology at Hadassah, Prof. Tamir Ben-Hur on Its Scientific Advisory Board - PRNewsWire
3 months ago - NewcelX CEO Issues Letter to Shareholders - PRNewsWire
3 months ago - NewcelX Provides Business and Strategic Roadmap Update Following Closing of Merger with NLS Pharmaceutics Ltd. - PRNewsWire

More News